ACLX has been in the news 1500% more than usual
Feb 23, 2026, 11:33 PM
0.00%
ACLX has been in the news recently: Gilead Sciences (NASDAQ: GILD) announced it will acquire Arcellx (NASDAQ: ACLX) to bolster its long-term oncology prospects. Halper Sadeh LLP is investigating the proposed sale—reported at $115 per share plus a $5 contingent value right—and is urging Arcellx shareholders to seek free legal assistance.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.